Chemical Bonding Material Applied To Wound Edges Patents (Class 606/214)
-
Publication number: 20110125187Abstract: A light activated collagen-flavin composite layer incorporating riboflavin is applied as treatment for infected lesions caused by bacteria and as the consequence of surgical procedures. These composites have also been found to be strong tissue adhesives that are effective in closing and sealing wounds, fixation of grafts/implants and anastomoses. Advantages include speed of closure, reduced infection due to the elimination of foreign matter, evidence of accelerated wound healing and the ease of use in complex surgery, especially when watertight seals, limited access or small repair size are important factors. The riboflavin in the collagen layer is exposed to light (e.g., light having a wavelength between 360-375 nm or 440-480 nm), decomposing the riboflavin to form reactive oxygen species (ROS). Strong crosslinks between the collagen composite and tissue results. In addition, similar exposures eradicate pathogens in the wound is eradicated resulting in a sterile wound.Type: ApplicationFiled: November 10, 2010Publication date: May 26, 2011Inventors: Barbara A. Soltz, Robert Soltz
-
Publication number: 20110104280Abstract: A multi-arm poly(ethylene glycol) (PEG) Succinimidyl Glutarate is mixed with a biocompatible, synthetic, nucleophilic polymer component essentially free of human or bovine albumin and other biological molecules, containing, e.g., a polypeptide moiety having a number of active surface lysines of at least twenty (20) per 5000 M/W, which can also be blended with a multi-arm poly(ethylene glycol) (PEG) Amine. The mixture forms a synthetic hydrogel composition. The synthetic hydrogel composition can be applied by topically spraying the synthetic hydrogel composition onto a targeted wound site to promote wound healing.Type: ApplicationFiled: May 20, 2010Publication date: May 5, 2011Inventor: Olexander Hnojewyj
-
Patent number: 7927414Abstract: An acellular matrix glue and a method of making is disclosed. Specifically, an acellular matrix glue that is useful in preparing a reinforced acellular matrix for medical applications including tissue engineering and hernia repair.Type: GrantFiled: September 5, 2008Date of Patent: April 19, 2011Assignee: Ethicon, Inc.Inventors: Chunlin Yang, Thomas Matalenas, Raymond S. Shissias, Kerstin Spychaj
-
Publication number: 20110082498Abstract: A method for sternal closure of a separated sternum includes applying an adhesive to a portion of an incision between at least a first sternum portion and at least a second sternum portion and maintaining the first sternum portion proximate to the second sternum portion until the adhesive has bonded with the first sternum portion and the second sternum portion. The adhesive may be applied over substantially the entire length of the incision or may be applied in intervals. The method for sternal closure may also include compressing the first sternum portion and the second sternum portion together using one or more compression devices and introducing adhesive to contact regions where the compressive devices contact the sternum. The method may also include cutting an interface feature in the first and second sternum portions or spanning the incision between the first and second interface portions with a structural support.Type: ApplicationFiled: October 7, 2009Publication date: April 7, 2011Applicant: DOCTORS RESEARCH GROUP, INC.Inventors: Richard J. Deslauriers, Eric Kolb
-
Publication number: 20110077684Abstract: The invention relates to novel polyvinyl alcohol (PVA) gels which gelate in situ and are suitable for nucleus (gel bodies of the intervertebral disks) replacement, and to a process and to an apparatus for administration thereof, to the use thereof and to a vessel which comprises an inventive PVA gel.Type: ApplicationFiled: May 27, 2009Publication date: March 31, 2011Applicant: Innogel AGInventors: Rolf Mueller, Federico Innerebner, Thomas Steffen, Norbert Boos
-
Publication number: 20110066182Abstract: ClotFoam is a surgical sealant and hemostatic agent designed to be used in cases of non-compressible hemorrhage. It can be applied in the operating room through laparoscopic ports, or directly over lacerated tissue in laparotomy procedures or outside the operating room through a mixing needle and/or a spray injection method following abdominal, chest, extremities or other intracavitary severe trauma to promote hemostasis. Its crosslinking technology generates an adhesive three-dimensional polymeric network or scaffold that carries a fibrin sealant required for hemostasis. When mixed, Clotfoam produces a foam that spreads throughout a body cavity reaching the lacerated tissue to seal tissue and promote the coagulation cascade. The viscoelastic attachment properties of the foam as well as the rapid formation of a fibrin clot that ensure that the sealant remains at the site of application without being washed away by blood or displaced by movement of the target tissue .Type: ApplicationFiled: March 30, 2010Publication date: March 17, 2011Applicant: BIOMEDICA MANAGEMENT CORPInventor: George Falus
-
Publication number: 20110066183Abstract: Apparatus for sealing a puncture communicating with a blood vessel includes a porous carrier formed from lyophilized hydrogel or other material. The plug may include at least first and second hydrogel precursors and a pH adjusting agent carried by the porous carrier in an unreactive state prior to exposure to an aqueous physiological environment. Once exposed to bodily fluids, the carrier expands as the lyophilized material hydrates to enhance and facilitate rapid hemostasis of the puncture. When the plug is placed into the puncture, the natural wetting of the plug by bodily fluids (e.g., blood) causes the first and second precursors to react and cross-link into an adhesive or “sticky” hydrogel that aids in retaining the plug in place within the puncture.Type: ApplicationFiled: September 7, 2010Publication date: March 17, 2011Applicant: Incept, LLCInventors: Amarpreet S. Sawhney, Farhad Khosravi, Suresh S. Pai
-
Publication number: 20110046607Abstract: The present invention provides a self-withdrawing catheter device for injection of material into a body passageway, comprising: a) a highly-flexible elongated shaft including at least one injection channel, attachable to a syringe; b) a canopy attached to the shaft near the distal end, the canopy providing smooth self-withdrawal of the catheter from within a body passageway, due to backward fluid pressure exerted upon said canopy after injection of material through said catheter. The invention also provides a surgical method and kit for fistular repair, comprising the afore-mentioned catheter, an additional balloon catheter for injecting fluids to clear a fistula, a debriding brush, a guide wire for aiding in inserting the components into the fistula, and hooks and ties for connecting these elements and drawing them into the fistula.Type: ApplicationFiled: May 2, 2006Publication date: February 24, 2011Applicant: RESQMEDICAL LTD.Inventor: Haim Halevy
-
Publication number: 20110046574Abstract: A wound closure apparatus is provided which utilizes blood fluid by activating the clotting cascade of blood fluid outside the body within a substantially enclosed sterile container then introducing the blood fluid to the wound site to complete clotting. An apparatus for providing ways of inhibiting anticoagulating agents and slowing fibrin clot degradation are also disclosed. Kits for practicing the invention singularly or in combination with and/or associated with preferred procedures are also disclosed. The invention provides a clotting cascade initiation apparatus including a substantially enclosed sterile containment chamber within which an aliquot of blood fluid, either autologous or from donor sources, can be received and retained. In preferred embodiments, the sterile containment chamber further includes a heparin binding agent which will bind heparin and remove it from the blood fluid.Type: ApplicationFiled: October 29, 2010Publication date: February 24, 2011Inventors: Karol L. Nowakowski, James E. Olson, Edward T. Joseph, Daniel G. Ericson
-
Publication number: 20110040323Abstract: The present invention relates to a combination, in particular for the adhesive bonding and/or fixing of biological and/or synthetic tissues, wherein the combination comprises the components a) a nitrogen-functionalized polysaccharide and b) a terminally functionalized oligolactone.Type: ApplicationFiled: August 1, 2008Publication date: February 17, 2011Applicants: AESCULAP AG, UNIVERSITÄT ROSTOCKInventors: Erich Odermatt, Jürgen Wegmann, Katrin Sternberg, Detlef Behrend
-
Publication number: 20110034954Abstract: A method of treating a heart condition includes dispensing first and second sealant components to a myocardial infarction via an introducer extending through a percutaneous puncture in a subxiphoid region. The first and second sealant components combine to form a medical sealant material that bonds to the myocardial infarction to form a reinforcement for the myocardial infarction, wherein the reinforcement does not include a patch.Type: ApplicationFiled: October 20, 2010Publication date: February 10, 2011Applicant: PACESETTER, INC.Inventors: Jiahong Tan, Edward Sarnowski, Kevin L. Morgan
-
Publication number: 20110027216Abstract: Tissue adhesives formed by crosslinking albumin and/or gelatin with certain polyamines and/or polycarboxylates using a water-soluble carbodiimide are disclosed. The use of the tissue adhesives for medical and veterinary applications such as topical wound closure; and surgical procedures, such as intestinal anastomosis, vascular anastomosis, tissue repair, and ophthalmic procedures; drug delivery; anti-adhesive applications; and as a bulking agent to treat urinary incontinence are described.Type: ApplicationFiled: October 14, 2010Publication date: February 3, 2011Applicant: E.I. DU PONT DE NEMOURS AND COMPANYInventor: Henry Keith CHENAULT
-
Publication number: 20110022082Abstract: A wound (50) is closed using a first adhesive shoe (10) adhesively affixed adjacent to a first edge (51) of the wound, a second adhesive shoe (20) adhesively affixed adjacent to a second opposite edge (52) of the wound, a forceps device (100) comprising a first leg (101 ) adapted to couple with the first adhesive shoe and a second leg (102) adapted to couple with the second adhesive shoe; and a locking mechanism (150) adapted to draw the first and second forcep legs together and hold legs in the desired closed position after they are drawn together.Type: ApplicationFiled: September 14, 2007Publication date: January 27, 2011Inventors: Kenneth Burke, Gary Baier
-
Publication number: 20110004240Abstract: An object of the present invention is to provide a water soluble bioadhesive that is curable by visible light irradiation. The present invention provides a visible light curable adhesive, which comprises a water soluble oxygen sensitizer that generates radicals under visible light irradiation and a water soluble polymer compound having a functional group that can be activated via singlet oxygen generated from the oxygen sensitizer under visible light irradiation.Type: ApplicationFiled: February 6, 2009Publication date: January 6, 2011Applicant: RikenInventors: Yoshihiro Ito, Tae-il Son, Yusuke Tajima
-
Publication number: 20110004241Abstract: Methods comprising: providing a migrate-sensitive substrate having a surface to be bonded; providing an adhesive formulation comprising an isocyanate-terminated polyurethane prepolymer containing one or more tertiary amino groups; and forming a migrate-free adhesive bond between the surface of the migrate-sensitive substrate and a second surface; as well as adhesive formulations comprising an isocyanate-terminated polyurethane prepolymer containing one or more tertiary amino groups; and wound closure systems comprising such an adhesive formulation.Type: ApplicationFiled: February 6, 2009Publication date: January 6, 2011Applicant: BAYER MATERIALSCIENCE AGInventors: Matthias Wintermantel, Christos Karafilidis, Heinz-Werner Lucas
-
Publication number: 20100312273Abstract: The technology described herein provides an apparatus and associated methods for the rapid percutaneous occlusion of a vascular access site. In one exemplary embodiment, a combined vascular and closure sheath is provided. This device includes a vascular sheath having a vascular sheath lumen, a proximal end and a distal end, and an exterior surface. The combined vascular and closure sheath includes a closure sheath, being lesser in length and greater in diameter than the vascular sheath and having a proximal end and a distal end, disposed circumferentially around the exterior surface of the vascular sheath at the proximal end of the vascular sheath, thereby forming a closure sheath lumen between the exterior surface of the vascular sheath and an interior surface of the closure sheath, the closure sheath being configured operably to eject a fluid such as a coagulant, a tissue sealant, and the coagulation protein thrombin.Type: ApplicationFiled: June 3, 2009Publication date: December 9, 2010Inventor: Robert E. Kim
-
Publication number: 20100312274Abstract: A device for the application of two components of fibrin adhesive at a treatment site comprising a support for syringes comprising two parallel cylindrical housings to receive corresponding syringes and a plunger connecting member, characterised in that the said syringe support comprises a passage for insertion of the said plunger connecting member, the said passage being located in the space defined between the cylindrical housings of the said syringe support, the said plunger connector having a zone with a suitable geometry to slide within the said passage and in that the transverse cross-section of the said passage of the syringe support has a maximum opening at the ends and a minimum opening in the central part.Type: ApplicationFiled: April 14, 2010Publication date: December 9, 2010Applicant: GRIFOLS, S.A.Inventor: Jorge Maria MANZANO RIERA
-
Publication number: 20100301094Abstract: Embodiments include a surgical device and a method. An embodiment of the surgical instrument includes at least one grasping jaw, the at least one grasping jaw being adapted to deliver surgical staples by a force generated from a force generator mechanism that is contained within the at least one grasping jaw or is in a proximity to the at least one grasping jaw. Another embodiment includes at least one grasping jaw, at least one actuation mechanism adapted to deliver surgical staples, the actuation mechanism being located in a proximity to or contained within the at least one grasping jaw, the surgical staples containing at least one shape-transforming material, at least one sensor, at least one chemical tissue sealant and at least one cutter. A method includes: grasping a body tissue with at least one grasping jaw, adjusting a configuration of the grasping in response to a signal or a datum or an image, and releasing a surgical staple/fastener in response to the signal, datum or image.Type: ApplicationFiled: July 27, 2010Publication date: December 2, 2010Inventors: Edward S. Boyden, Roderick A. Hyde, Muriel Y. Ishikawa, Eric C. Leuthardt, Nathan P. Myhrvold, Dennis J. Rivet, Michael A. Smith, Clarence T. Tegreene, Thomas A. Weaver, Charles Whitmer, Lowell L. Wood, JR., Victoria Y.H. Wood
-
Patent number: 7842070Abstract: A sheath introducer is inserted through the skin and into a body lumen, e.g., the femoral artery, for a medical procedure. Upon completion of the medical procedure, the sheath introducer is partially withdrawn from the body lumen so that at least one through-wall hole in a body region of the sheath introducer is positioned outside the body lumen, but under the skin. An opening in a distal end tip of the sheath introducer is sealed so that no blood is flowing into the sheath introducer the after sheath introducer is partially withdrawn. A surgical sealant is injected into the sheath introducer and flows out of the at least one through-wall hole and surrounds the access site. After injection of the surgical sealant, the sheath introducer is removed. The surgical sealant seals the puncture and minimizes any blood flow from the body lumen through the puncture.Type: GrantFiled: December 1, 2005Date of Patent: November 30, 2010Assignee: Medtronic Vascular, Inc.Inventor: Jerry Brightbill
-
Publication number: 20100297235Abstract: A hydrogel composition for application to vascular puncture site of an animal to arrest bleeding and promote hemostasis mixes a biocompatible, synthetic, electrophilic polymer component comprising a poly(ethylene glycol) (PEG) Succinimidyl Glutarate having a functionality of four and a molecular weight of about 10,000 g/mole, with a biocompatible, synthetic, nucleophilic polymer component comprising a blend of a poly(ethylene glycol) (PEG) Amine having a functionality of four and a molecular weight of about 10,000 g/mole, and a Poly-L-Lysine hydrobromide having a molecular weight of greater than about 8000 g/mole.Type: ApplicationFiled: May 20, 2009Publication date: November 25, 2010Inventor: Olexander Hnojewyj
-
Patent number: 7838630Abstract: The invention provides composition and methods for repairing a ruptured anterior cruciate ligament.Type: GrantFiled: March 29, 2005Date of Patent: November 23, 2010Assignee: Children's Medical Center CorporationInventors: Martha M. Murray, Michael F. Murray, Jennifer Marler
-
Patent number: 7838718Abstract: The disclosed two-component device includes a first component comprising a first adhesive-backed anchoring member and one or more first connecting members, produced separately from the first adhesive-backed anchoring member. The first connecting member is attached to the first adhesive-backed anchoring member, extending from One edge thereof in a first direction. Also disclosed is a second component comprising a second adhesive-backed anchoring member and one or more second connecting members, produced separately from the second adhesive-backed anchoring member. The second component is attached to the second adhesive-backed anchoring member, extending from one edge thereof in a second direction generally opposite to the first direction. Adhesive for attaching the one or more first connecting members to the second anchoring member and adhesive for attaching the one or more second connecting members to the first anchoring member is provided. Methods of use are also disclosed.Type: GrantFiled: July 24, 2003Date of Patent: November 23, 2010Assignee: Clozex Medical, LLCInventor: Michael Lebner
-
Publication number: 20100280547Abstract: One aspect of the invention relates to a simple, inexpensive applicator system which can be used for the delivery of a hydrogel formulation. In certain embodiments, the applicator system is suitable for use in sealing of dura mater, especially dura matter within the spinal column. In other embodiments, the applicator system may be used to repair cardiovascular defects, defects of the gall or urinary bladder, or repair of any of the other ducts within the body.Type: ApplicationFiled: April 30, 2010Publication date: November 4, 2010Applicant: HyperBranch Medical Technology, Inc.Inventors: Keith R. D'Alessio, Michael A. Carnahan, Jared D. G. Butlin
-
Publication number: 20100272804Abstract: A tissue adhesive formed by reacting an oxidized cationic polysaccharide containing aldehyde groups and amine groups with a multi-arm amine is described. The oxidized cationic polysaccharide-based polymer tissue adhesive may be useful for medical applications including wound closure, supplementing or replacing sutures or staples in internal surgical procedures such as intestinal anastomosis and vascular anastomosis, ophthalmic procedures, drug delivery, anti-adhesive applications and as a bulking agent to treat urinary incontinence. Additionally, due to the presence of the positively charged amine groups on the oxidized polysaccharide, the polymer tissue adhesive disclosed herein may promote wound healing and blood coagulation, and may possess antimicrobial properties.Type: ApplicationFiled: November 14, 2008Publication date: October 28, 2010Applicant: E. I. DU PONT DE NEMOURS AND COMPANYInventor: Helen S.M. Lu
-
Publication number: 20100262141Abstract: A surgical instrument including an injection device and a dosing device. These devices are designed such that a predetermined amount of an adhesive or an adhesive containing filler can be injected into a sealing section of the blood vessel. The blood vessel can then be cut at the filled point and is sealed on both sides.Type: ApplicationFiled: November 4, 2008Publication date: October 14, 2010Inventors: Daniel Schäller, Matthias Voigtländer, Klaus Fischer, Mara Szyrach, Lars Blobel, Irina Sigle
-
Publication number: 20100256671Abstract: ClotFoam is an hemostatic agent designed for non-compressible hemorrhage. It can be applied outside the operating room through a mixing needle and/or a spray injection method following abdominal, chest, extremities or other intracavitary severe trauma to promote hemostasis, or it can be used in the operating room for laparoscopic procedures or other surgical procedures in which compression is not possible or recommended. Its crosslinking technology generates an adhesive three-dimensional polymeric network or scaffold that carries a fibrin sealant required for hemostasis. When mixed, Clotfoam produces a foam that spreads throughout a body cavity reaching the lacerated tissue to seal tissue and promote the coagulation cascade. The viscoelastic attachment properties of the foam as well as the rapid formation of a fibrin clot that ensure that the sealant remains at the site of application without being washed away by blood or displaced by movement of the target tissue .Type: ApplicationFiled: April 7, 2009Publication date: October 7, 2010Applicant: BIOMEDICA MANAGEMENT CORPORATIONInventor: George Falus
-
Publication number: 20100256672Abstract: A method and apparatus for closing a gap between tissues, comprising introducing a device head into the gap, applying a force to a portion of one tissue with the device head, applying a force to a portion of the other tissue with the device head, moving, via the device head, the first tissue into close proximity to the second tissue, maintaining, for a predetermined period of time via the device head, the one tissue and the other tissue in close proximity until the portion of the one tissue and the portion of the other tissue become cellularly adhered to one another, thereby forming a cellular aggregate connecting the tissues, and releasing from the device head the portion of the one tissue, the portion of the other tissue, and the cellular aggregate after a predetermined period of time of less than about one minute.Type: ApplicationFiled: March 30, 2010Publication date: October 7, 2010Applicant: WEINBERG MEDICAL PHYSICS LLCInventors: Irving Weinberg, Mario Urdaneta, Pavel Stepanov, Elisabeth Smela
-
Publication number: 20100249698Abstract: The present invention is directed to curable cyanoacrylate-based formulation containing a multi-functional amine initiator. A dual function amine, particularly Quadrol, provides a highly desirable balance of maximum cure temperature and setting time of cure with the same higher viscosity, non-running cyanoacrylate formulation. The present invention is also directed to systems that utilize the inventive formulations and methods for use of such formulations.Type: ApplicationFiled: March 31, 2009Publication date: September 30, 2010Inventors: Binoy K. Bordoloi, Melanie A. Vander Klok
-
Patent number: 7803172Abstract: Apparatus for sealing a puncture communicating with a blood vessel includes a porous carrier formed from lyophilized hydrogel or other material. The plug may include at least first and second hydrogel precursors and a pH adjusting agent carried by the porous carrier in an unreactive state prior to exposure to an aqueous physiological environment. Once exposed to bodily fluids, the carrier expands as the lyophilized material hydrates to enhance and facilitate rapid hemostasis of the puncture. When the plug is placed into the puncture, the natural wetting of the plug by bodily fluids (e.g., blood) causes the first and second precursors to react and cross-link into an adhesive or “sticky” hydrogel that aids in retaining the plug in place within the puncture.Type: GrantFiled: January 25, 2007Date of Patent: September 28, 2010Assignee: AccessClosure, Inc.Inventors: Farhad Khosravi, Suresh S. Pai, Celso J. Bagaoisan
-
Publication number: 20100241163Abstract: An aortic dissection treatment system and method of use including a treatment system for an aortic dissection having a catheter defining a suction lumen and a sealant lumen; a flexible cup defining an isolation region within the flexible cup, the isolation region being in communication with the suction lumen and the sealant lumen; and a sealant fluid deliverable to the aortic dissection through the sealant lumen and the isolation region. The flexible cup is sized to fit over at least one end of the aortic dissection and the suction lumen applies suction to maintain the flexible cup over the at least one end of the aortic dissection.Type: ApplicationFiled: March 23, 2009Publication date: September 23, 2010Applicant: Medtronic Vascular, Inc.Inventors: Josiah Wilcox, Julie Trudel, James Machek
-
Publication number: 20100234861Abstract: A staple line buttress material having an adhesive surface, packaged and provided in sterile, ready-to-use form. The material can be used to retrofit surgical staplers to provide an improved staple line, and with improved ease of use.Type: ApplicationFiled: March 22, 2010Publication date: September 16, 2010Applicant: SYNOVIS LIFE TECHNOLOGIES, INC.Inventors: B. Nicholas Oray, Daniel L. Mooradian
-
Publication number: 20100230467Abstract: According to an aspect of the present disclosure, an apparatus for forming an anastomosis between adjacent sections of tissue is provided. The apparatus includes a body portion; an actuation assembly operatively supported at a proximal end of the body portion; an anvil assembly movably mounted at the distal end of the body portion for movement toward and away from the body portion; an approximation assembly extending between the body portion and the anvil assembly for moving the anvil toward and away from the tubular body portion; a dispersion assembly operatively associated with the approximation assembly, the dispersion assembly including at least one angled surface defining at least one channel interposed between the anvil assembly and the body portion and being configured to dispense a fluid therefrom; and at least one conduit for conducting wound treatment material to the dispersion assembly.Type: ApplicationFiled: March 31, 2010Publication date: September 16, 2010Inventors: Christopher J. Criscuolo, Michael J. Bettuchi
-
Publication number: 20100204718Abstract: Disclosed are compositions, methods, and kits for joining together non-conjoined lumens in a patient's body including vascular lumens. More particularly, in various aspects, this invention provides compositions, methods, and kits for joining such non-conjoined lumens, including small lumens typically requiring microsurgical technique.Type: ApplicationFiled: February 6, 2009Publication date: August 12, 2010Inventors: C. Travis Rappleye, Joseph Rimsa, Drew A. Hoffmann
-
Publication number: 20100198255Abstract: A spray head (30) for an applicator (1) for applying biological tissue bonding agent to an affected area, where the bonding agent is produced by spraying and mixing solutions respectively received in a pair of syringes (2 (2a, 2b)). The spray head (30) has a first nozzle opening (42a) from which the solution received in either one (2a) of the syringes is jetted in a predetermined jetting direction, and also has a second nozzle opening (42b) from which the solution received in the other syringe (2b) is jetted in the direction same as or substantially the same as the predetermined jetting direction. The second nozzle opening (42b) is placed forward in the jetting direction from the first nozzle opening (42a).Type: ApplicationFiled: June 11, 2008Publication date: August 5, 2010Applicant: JURIDICAL FDN THE CHEMO-SERO-THERAPEUTIC RES. INS.Inventors: Yoshihiro Ifuku, Keisuke Fujiwara, Noriyasu Kaihara, Yasunari Miyazaki
-
Patent number: 7766938Abstract: The invention discloses a method of treating a patient for pleural effusion comprising percutaneously delivering an adhesive material to a pleural space of the patient. Suitable adhesive materials for performing any of the embodiments of the methods of the invention can be selected from the group consisting of hydrogels, collagen, poly(lactic acid), poly(glycolide), cyanoacrylates, glutaraldehyde, PEG, protein, and polysaccharide and derivatives thereof. The invention also discloses a pleural effusion treatment apparatus comprising an adhesive material adapted to adhere pleural membranes defining a pleural space and a pleural space access member adapted to deliver the adhesive material to the pleural space.Type: GrantFiled: July 8, 2005Date of Patent: August 3, 2010Assignee: PneumRx, Inc.Inventors: Erin McGurk, Ronald Dieck, Charles Wartchow, Glen Gong, Jobert Balceta
-
Publication number: 20100191281Abstract: A device for delivering a biocompatible material to a surgical site includes a cannula having proximal and distal portions and at least a first interior lumen disposed therebetween through which the biocompatible material is delivered. The device further includes an initiation member for initiating cross-linking of the biocompatible material while the biocompatible material is within the cannula. The cannula may include a heating element to thermally initiate cross-linking. Alternately, the cannula may include a second lumen for transmitting light from a light source. A movable blocking element controls the amount of light that passes into the first lumen. A method of delivering a curable biocompatible material to a surgical site includes positioning a distal portion of a cannula adjacent the surgical site and introducing the biocompatible material through a first lumen of the cannula. Cross-linking of the biocompatible material is then initiated while the biocompatible material is within the cannula.Type: ApplicationFiled: March 31, 2010Publication date: July 29, 2010Inventors: Essy Behravesh, Jian Q. Yao, Xiao Huang, Victor Zaporojan, Jizong Gao
-
Publication number: 20100166834Abstract: The present invention provides a preparation comprising fibrinogen and a sulfated polysaccharide as a one component composition or as a kit of parts comprising fibrinogen and sulfated polysaccharide as separated components. The present invention further provides a fibrin clot like structure obtainable by a defined process, a hemostatic patch, a two-component syringe system and various uses of the described preparations, fibrin clot like structures and patches.Type: ApplicationFiled: December 11, 2009Publication date: July 1, 2010Applicants: Baxter International Inc., Baxter Healthcare S.A.Inventors: Michael Dockal, Friedrich Scheiflinger, Hans Christian Hedrich, Klaus Tschetschkowitsch
-
Publication number: 20100168779Abstract: A laparoscopic tissue sealant spray apparatus and system having a laparoscopic tissue sealant spray assembly combined with a trocar assembly, the tissue sealant spray assembly having an elongate delivery tube. A spray outlet at a distal end of the elongate delivery tube may be rounded or angled. A ring member provided at the distal end of the elongate delivery tube directs a spray cone toward a portion of a target tissue site, and the spray cone may be repositioned to a different portion of the target tissue site by rotation of the elongate delivery tube. The trocar assembly includes a vent opening that connects to a venting valve member that provides a vent path which passively opens upon operation of the tissue sealant spray assembly, avoiding excessive pressure build-up within a body cavity.Type: ApplicationFiled: December 30, 2009Publication date: July 1, 2010Applicants: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE S.A.Inventors: Heinz Redl, Zafar Khakpour, Rene Fortelny
-
Patent number: 7744624Abstract: An apparatus for applying sealant to a target tissue of a surgical site is provided. The apparatus includes a handle, conduit and an end effector. The handle has means configured and adapted for operating the end effector and dispensing biological sealant to the surgical site via the end effector. The conduit stores and/or carries sealant towards the end effector. The end effector is configured to clamp around a body organ or tissue and apply and confine biological sealant in a substantially uniform manner thereto.Type: GrantFiled: October 14, 2005Date of Patent: June 29, 2010Assignee: Tyco Healthcare Group LPInventor: Michael Bettuchi
-
Publication number: 20100160960Abstract: A hydrogel tissue adhesive having increased degradation time is described. The hydrogel tissue adhesive is formed by reacting an oxidized polysaccharide with a water-dispersible, multi-arm amine in the presence of a polyol additive, which retards the degradation of the hydrogel. The hydrogel may be useful as a tissue adhesive or sealant for medical applications, including but not limited to, ophthalmic applications such as sealing wounds resulting from trauma such as corneal lacerations, or from surgical procedures such as vitrectomy procedures, cataract surgery, LASIK surgery, glaucoma surgery, and corneal transplants; neurosurgery applications, such as sealing the dura; as a plug to seal a fistula or the punctum; adhesion prevention to prevent undesired tissue to tissue adhesions resulting from trauma or surgery; and as a hemostat sealant.Type: ApplicationFiled: November 9, 2009Publication date: June 24, 2010Applicant: E. I. DU PONT DE NEMOURS AND COMPANYInventors: Mark E. Wagman, Kai Qi, Keith Kunitsky, Hing Wan Yim
-
Publication number: 20100145369Abstract: Bioabsorbable compounds which include a polyalkylene oxide backbone with two or more isocyanate substituents are useful as one component adhesives. Absorbable compositions useful as a two component adhesive contain a) a polyethylene oxide having two or more amine substituents with b) a bioabsorbable diisocyanate compound, or alternatively contain a) a polyethylene oxide having two or more isocyanate substituents with b) a bioabsorbable diamine compound, or, alternatively contain a) a bioabsorbable diisocyanate compound and b) a bioabsorbable diamine compound.Type: ApplicationFiled: February 18, 2010Publication date: June 10, 2010Applicant: TYCO HEALTHCARE GROUP LPInventor: Mark S. Roby
-
Publication number: 20100114158Abstract: Embodiments of a delivery device, a kit comprising the delivery device, and methods of using the same are presented. In one embodiment, the delivery device includes a syringe assembly defining two or more reservoirs each configured to hold a dispensable material. Additionally, the delivery device may include a delivery tip. The delivery tip may have an inlet, an outlet, a central flow-restricting portion, and one or more channels adjacent to the central flow-restricting portion that provide fluid communication between the inlet and the outlet, the one or more channels including a section that tapers inwardly toward the outlet. In one embodiment, the delivery device is configured such that if the two or more reservoirs hold dispensable material then the syringe assembly can be actuated to dispense the dispensable material from the two or more reservoirs substantially simultaneously into the inlet.Type: ApplicationFiled: September 28, 2009Publication date: May 6, 2010Applicant: NERITES CORPORATIONInventors: Paul Hattan, John O. White, Jason Gerold
-
Publication number: 20100100124Abstract: Compounds are provided which can form bioabsorbable compositions useful as adhesives and/or sealants for medical/surgical applications.Type: ApplicationFiled: October 20, 2009Publication date: April 22, 2010Applicant: TYCO HEALTHCARE GROUP LPInventors: Allison Calabrese, Walter Skalla
-
Patent number: 7700562Abstract: The present invention relates to use of convertase inhibitors for the reduction of scarring during the healing of wounds and also for reducing fibrosis in the treatment of fibrotic conditions.Type: GrantFiled: July 23, 2003Date of Patent: April 20, 2010Assignee: Renovo LimitedInventors: Mark William James Ferguson, Georg Brunner
-
Publication number: 20100087804Abstract: A method and system for tissue treatment, wherein the method includes transmitting energy onto tissue to be treated, and maintaining a required distance, during the tissue treatment, between a hand piece and the tissue. The method may further include applying a soldering agent for facilitating tissue soldering, used as adhesive to various types of protein in human tissue, wherein the transmitting energy activates the soldering agent applied on the tissue.Type: ApplicationFiled: November 1, 2007Publication date: April 8, 2010Inventors: Ofer Fridman, Ishay Attar, Ziv Attar
-
Publication number: 20100076429Abstract: The present disclosure relates to surgical instruments including a staple anvil formed in a distal end of the surgical stapler and a staple cartridge selectively receivable in a distal end of the surgical stapler and in juxtaposition relative to the staple anvil, the staple cartridge including one or more laterally spaced apart rows of staple slots formed in an upper surface thereof, a plurality of surgical staples disposed, one each, within the staple slots, and a staple line reinforcing system configured and adapted to augment the strength of the staple line formed by the firing of the surgical staples into body tissue, wherein the surgical stapler concomitantly drives the plurality of surgical staples through the adjacent layers of body tissue to mechanically secure the body tissue and activates the reinforcing system to non-mechanically secure the adjacent layers of body tissue to one another.Type: ApplicationFiled: December 2, 2009Publication date: March 25, 2010Applicant: TYCO HEALTHCARE GROUP LPInventor: Russell HEINRICH
-
Publication number: 20100076486Abstract: Disclosed herein are methods for treating a defect in a spinal disc nuclear space, comprising: (a) creating an opening by open, percutaneous or laparoscopic techniques to access the defect in the nuclear space; (b) removing a desired amount of tissue from the nuclear space; (c) positioning a delivery catheter through the opening; (d) fluidically isolating the nuclear space by blocking the opening with a blocking component of the catheter; (e) delivering an in-situ curable liquid material through a lumen of the catheter to the nuclear space; and (f) maintaining the isolating until the liquid material has cured. Also disclosed are treatment systems and materials for prostheses.Type: ApplicationFiled: October 8, 2009Publication date: March 25, 2010Applicant: Promethean Surgical Devices, LLCInventors: Jeffrey A. Wilson, Michael T. Milbocker, Robert M. Arcangeli
-
Publication number: 20100069927Abstract: One aspect of the present invention generally relates to methods of sealing a defect, wound or void using a two component system composed of masking material, which creates an anti-adhesion barrier, and a covering material. In certain embodiment, the covering material comprises an in situ polymerizing sealant. In certain embodiments, the in situ polymerizing sealant is a hydrogel which binds to the healthy tissue but remain unadhered to the area under the masking material. In certain embodiments, the masking material is also a hydrogel. In certain embodiments, normal biological processes may dissolve away the masking material leaving a protective cover of polymerized sealant over the wound site.Type: ApplicationFiled: July 22, 2008Publication date: March 18, 2010Applicant: HyperBranch Medical Technology, Inc.Inventors: Jeffrey G. Clark, Robert Naslund, Kenneth E. Stockman
-
Patent number: 7678133Abstract: Devices and methods for biological tissue closure are disclosed. Arteriotomy closure and hemostasis devices and methods are disclosed. A device that can provide a lateral tension across an opening in the tissue and apply energy to seal the tissue is disclosed. Methods for using the device are also disclosed.Type: GrantFiled: July 10, 2004Date of Patent: March 16, 2010Assignee: Arstasis, Inc.Inventor: D. Bruce Modesitt
-
Publication number: 20100063539Abstract: An acellular matrix glue and a method of making is disclosed. Specifically, an acellular matrix glue that is useful in preparing a reinforced acellular matrix for medical applications including tissue engineering and hernia repair.Type: ApplicationFiled: September 5, 2008Publication date: March 11, 2010Inventors: Chunlin Yang, Thomas Matalenas, Raymond S. Shissias, Kerstin Spychaj